Capitalize on New Commercial Opportunities in Rare & Autoimmune Disease
As the autoimmune neuromuscular space rapidly evolves, biopharma is facing a critical bottleneck: the science is advancing faster than the tools needed to translate it. While innovation across FcRn, complement and B-cell pathways has transformed the MG landscape and expanded into CIDP, GBS and MMN, developers are still constrained by poorly predictive preclinical models, limited biomarker validation and challenges executing trials in small, heterogeneous patient populations.
In a space where biopharma has emphasized a lack of awareness of specialised vendors, there is an urgent need for human-relevant in vitro systems that capture immune–neuromuscular interactions, translatable in vivo models that reflect true disease biology, validated biomarker platforms for patient stratification, and CRO partners with rare disease expertise. Yet dissatisfaction remains high, models lack fidelity, biomarkers are not regulatory-ready, and few solution providers truly specialise in these indications.
The Autoimmune Neuromuscular & Nerve Disorders Drug Development Summit is designed to directly address these gaps. By convening biopharma leaders focused on mechanism, translation and clinical success, this forum creates a unique opportunity for solution providers to align their capabilities with real, unmet needs.
This is a chance to position your technology as a critical enabler of next-generation drug development in one of the most competitive and opportunity-rich therapeutic areas today.
What to Expect?
Meet High-Value Biopharma Clients
Engage face-to-face with a highly targeted audience of discovery, translational and clinical leaders actively developing therapies in MG, CIDP, GBS and MMN, all seeking solutions to overcome challenges in models, biomarkers and clinical execution.
Showcase Your Scientific & Technical Expertise
Position your capabilities within a mechanism-driven agenda focused on disease biology and translation. Contribute through presentations, panels or exhibitions to demonstrate how your solutions directly address key bottlenecks in neuromuscular drug development.
Position Your Brand at the Centre of a Rapidly Evolving Market
Align your organization with leading companies such as argenx, Alexion and Sanofi, and gain premium visibility across event materials, ensuring your brand is front-of-mind for teams making critical outsourcing and partnership decisions.
Gain Actionable Market Intelligence
Hear directly from industry leaders on emerging therapeutic strategies, biomarker needs and translational challenges, enabling you to refine your offering, anticipate demand and stay ahead in an increasingly competitive landscape.
Key Interest Areas
- In Vitro models that recapitulate complex immune interactions within nerves and muscles
- In Vivo models and preclinical CROs with translatable animal models of MG, CIDP, GBS or MMN
- Biomarker assays and diagnostics to support with autoantibody measurements, demyelination markers and more
- Clinical CROs with rare or autoimmune expertise
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We offer a range of tailored partnership opportunities, from exhibition booths and thought leadership speaking slots to more bespoke options such as branded networking sessions, private dinners and exclusive experiences, designed to position your solutions in front of biopharma teams tackling key challenges in autoimmune neuromuscular drug development.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Jessica Alarms
Partnerships Director
Maintain Your Competitive Edge
Position your solutions at the centre of a rapidly evolving autoimmune neuromuscular landscape and ensure your brand is part of the conversations shaping next-generation drug development.
Network With Decision-Makers
Connect with senior discovery, translational and clinical leaders actively advancing pipelines in MG, CIDP, GBS and MMN through dedicated networking sessions and interactive discussion formats.
Showcase Your Capabilities
Leverage tailored sponsorship opportunities, from thought leadership presentations to targeted branding and exhibition, to demonstrate how your solutions address critical challenges in models, biomarkers and clinical development.